How genome sequencing works

Every cell in your body carries a copy of the same instruction manual. It is written in DNA, and it tells your cells how to build and run you. The strange thing is that until very recently, nobody could read it.

It helps to think of DNA as a cookbook. Not one long story, but a collection of recipes called genes. One recipe sets your eye color. Another tells your liver how to break down food. Another runs part of your immune system. There are thousands of them, each handling something specific.

You got this cookbook from your parents, two copies of almost every recipe, one from each. Usually the two copies say the same thing. Sometimes they differ, and we call those spots variants. Most variants do nothing you would ever notice. A few change visible traits. And a small number matter: they can raise your risk for a condition, or change how a drug works in your body.

For almost all of history, this was invisible. A doctor could see the symptoms, the rash, the cough, the chest pain, but not the text underneath that explained them. The cookbook stayed shut.

Genome sequencing is how we open it. A lab takes a few of your cells, usually from a cheek swab, and copies the DNA over and over until there is enough for a machine to read. The machine then reads the order of the chemical letters, one after another. You have about three billion of them. Reading the whole thing is what people mean by whole-genome sequencing.

But reading is not the same as understanding. What comes out is just three billion letters, like a photo of every page with none of the meaning attached. So software lines your letters up against a reference copy of the human genome and flags every place yours differ. Then it checks those differences against decades of research that connects variants to genes, conditions, and drugs.

This second step is the hard one, and it is where the honest part of the story begins. Some genes have been studied for decades, so for certain variants we can say something real. For many others, the evidence is thin or still arriving. The book is only half written, and science is filling in the rest as it goes.

What does that look like? A harmful variant in HTT means you will develop Huntington's disease — that one is close to a yes or no. A pathogenic variant in BRCA1 does not guarantee cancer, but it can push lifetime breast cancer risk above 60%, which is why people bring it to a genetic counselor. Then there are scores built from hundreds of small variants together: you might land in the top 10% of genetic risk for heart disease even though no single gene jumps out. Same genome, very different kinds of answers.

That is the problem Manuscript exists to handle. We sequence your whole genome, run thousands of these checks, and then do the part that is easy to skip: we tell you what each finding actually means in plain English, how strong the evidence behind it is, and what people tend to bring up with a clinician. You can ask questions about your results too, because a list of gene names is useless if you cannot make sense of it.

One thing worth being clear about: this is educational, not a diagnosis. Sequencing can surface real things worth knowing, but anything significant should go to a qualified provider. Your DNA is one input, not the whole picture. Family history, how you live, and an actual exam all still matter.

The part you do is easy. You order a kit, swab your cheek, and mail it back. The lab reads your genome, we build the analysis, and a report shows up in your account, usually ten to twenty business days after the lab gets your sample.

So that is the whole arc. Your cells hold the instructions. Sequencing reads them. Software finds where you differ. Research explains what those differences might mean. And we turn all of it into something you can actually use.